ZBH
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc historical holders
total: 14
Ariel Focus Fund Zimmer Biomet Holdings Inc transactions over time
- Total transactions:
- 14
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 9
- Held since:
- 2019 Q3
- Held for:
- 16 quarters
- Latest activity:
- 2023 Q3
Charles Bobrinskoy has been an institutional investor in Zimmer Biomet Holdings Inc (ZBH) since 2019 Q3. According to 2026 Q1 report, Charles Bobrinskoy doesn't hold any shares. The fund/company first acquired ZBH in 2019 Q3, initially purchasing 19,700 shares. Since the initial investment, Ariel Focus Fund has made 13 more transactions in this position.
When did Charles Bobrinskoy exit their ZBH position?
Charles Bobrinskoy no longer holds Zimmer Biomet Holdings Inc (ZBH). They sold off their entire position in 2023 Q3, closing out an investment that began in 2019 Q3.
When did Charles Bobrinskoy first invest in ZBH?
Charles Bobrinskoy first invested in Zimmer Biomet Holdings Inc (ZBH) in 2019 Q3 at the reported quarter-end price of $137.27 per share, acquiring 19,700 shares in their initial purchase.
What is Charles Bobrinskoy's average cost basis for ZBH?
Based on historical transaction data, Charles Bobrinskoy's estimated cost basis for Zimmer Biomet Holdings Inc (ZBH) is approximately $137.43 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $137.43
- Weighted AVG sell price:
- $134.47
ZBH transactions history by Ariel Focus Fund
14 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q3
|
0.00%
|
0
|
$145.60
|
|
-100% (-2,873)
|
-0.63%
|
|
2023 Q2
|
0.63%
|
2,873
|
$145.60
|
$418,309
|
-57.80% (-3,935)
|
-0.87%
|
|
2023 Q1
|
1.34%
|
6,808
|
$129.20
|
$879,594
|
-13.06% (-1,023)
|
-0.21%
|
|
2022 Q4
|
1.61%
|
7,831
|
$127.50
|
$998,452
|
-30.91% (-3,503)
|
-0.79%
|
|
2022 Q3
|
2.09%
|
11,334
|
$104.55
|
$1,184,970
|
-19.92% (-2,820)
|
-0.48%
|
|
2022 Q1
|
2.43%
|
14,154
|
$127.90
|
$1,810,297
|
-9.61% (-1,504)
|
-0.27%
|
|
2021 Q4
|
2.80%
|
15,658
|
$127.04
|
$1,989,192
|
+9.15% (+1,313)
|
+0.24%
|
|
2021 Q3
|
3.41%
|
14,345
|
$146.36
|
$2,099,534
|
-2.75% (-405)
|
-0.09%
|
|
2021 Q2
|
3.56%
|
14,750
|
$160.82
|
$2,372,095
|
+2.08% (+300)
|
+0.07%
|
|
2020 Q4
|
4.18%
|
$154.09
|
-18.82% (-3,350)
|
|||
|
2020 Q3
|
5.44%
|
$136.14
|
-5.82% (-1,100)
|
|||
|
2020 Q2
|
4.91%
|
$119.36
|
-7.80% (-1,600)
|
|||
|
2019 Q4
|
4.91%
|
$149.68
|
+4.06% (+800)
|
|||
|
2019 Q3
|
4.80%
|
$137.27
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.